11
Sep
EASD 2024 | HighTide Therapeutics Presents Oral Reports of Phase 2 Studies
Top Stories Tamfitronics HONG KONG, Sept 11, 2024 - (ACN Newswire) - HighTide Therapeutics, Inc. (2511.HK), a clinical stage biopharmac...